Our Partnership Areas:
Advancing Medical Breakthroughs
We seek strong, long-term relationships that fit our goals and offer a shared vision.
Collaborating to Give Hope
Our recent collaboration with Abbott Molecular Diagnostics helped put Xalkori (crizotinib) on the fast track with FDA approval in August, giving patients with lung cancer an important treatment option.
Today, investment in R&D just isn't enough. Recognizing this change in the healthcare industry, we pursue partnerships to identify, develop and secure innovation wherever it occurs.
It's the power of innovation, including innovation through partnerships that drives us.
Join Us in Advancing Our Vision of a Healthier World
Are you looking to partner on an innovative product, novel technology, a new business process or an idea? Visit our Partnership areas for more information or
Includes Primary Care, Specialty Care, Oncology, Established Products and Emerging Markets Business Units
Advancing breakthrough medicines and vaccines
Core Therapeutic Areas
Outlines our priority Therapeutic Areas
Furthering innovation in healthcare through collaborative partnerships